```html

Wart (Verruca vulgaris) – Comprehensive Medical Guide

Overview

Wart (verruca vulgaris) is a benign skin growth caused by infection with certain types of human papillomavirus (HPV). The lesions most often appear on the hands, fingers, and knees but can develop anywhere on the skin. Although warts are non‑cancerous, they can be uncomfortable, unsightly, and sometimes spread to other body sites or people.

• Who it affects: All ages can develop warts, but they are most common in children and adolescents (approximately 7–12 % of school‑aged children) and in adults with weakened immune systems.
• Prevalence: The CDC estimates that up to 10 % of the U.S. population will have at least one wart at some point in life. Worldwide, the prevalence is similar, with higher rates in crowded living conditions where skin‑to‑skin contact is frequent.
• Natural history: Many warts resolve spontaneously within 2 months to 2 years, especially in children, but some persist for years and may require treatment.

Symptoms

Warts have a characteristic appearance, but they can vary in size, shape, and surface texture. Common symptoms include:

• Raised, rough‑surface lesion: Usually skin‑colored, flesh‑colored, or slightly brown.
• Black pinpoint dots: Small, hard, black spots are thrombosed capillaries (tiny blood vessels) inside the wart.
• Itching or tenderness: Some warts become painful when pressure is applied (e.g., on the soles).
• Bleeding: Scratching or trauma can cause minor bleeding.
• Spread to nearby skin: New, smaller warts (satellite lesions) may appear around the original lesion.
• Location‑specific variations:
  • Common warts – on fingers, knuckles, and elbows; dome‑shaped with a rough surface.
  • Flat warts – smoother, flatter, often on the face or forearms; may appear in clusters.
  • Plantar warts – on the soles of the feet; can feel like a stone under the skin.

Causes and Risk Factors

Cause

Warts are caused by infection with specific strains of human papillomavirus (HPV). Over 100 HPV types exist; for verruca vulgaris, the most common are HPV 1, 2, 4, and 27. The virus infects the epidermis, leading to rapid proliferation of keratinocytes (skin cells) and the formation of a wart.

How the virus spreads

• Direct skin‑to‑skin contact – touching a wart on another person or on yourself.
• Indirect contact – sharing towels, razors, shoes, or gym equipment.
• Autoinoculation – scratching a wart and then touching another skin area.

Risk factors

• Age: Children (5‑15 years) have the highest incidence.
• Immune status: Immunocompromised individuals (e.g., HIV, organ‑transplant recipients, patients on systemic steroids) are more prone to persistent or extensive warts.
• Skin integrity: Cuts, abrasions, or macerated skin (common on athletes’ feet) provide an entry point.
• Moist environments: Public showers, swimming pools, and communal locker rooms increase exposure.
• Occupational exposure: Healthcare workers, food‑service employees, and people who handle cash or tools frequently may have higher exposure.

Diagnosis

Diagnosis is primarily clinical—based on visual inspection and patient history. A qualified healthcare provider (primary‑care physician, dermatologist, or podiatrist) can usually recognize a wart without additional testing.

When additional tests are considered

• Dermoscopy: A handheld magnifying device that reveals the characteristic “frog‑spawn” pattern of thrombosed capillaries.
• Biopsy: Rarely needed, but a shave or punch biopsy may be performed if the lesion is atypical, rapidly growing, or suspicious for skin cancer.
• HPV typing: Molecular PCR testing is used mainly in research or in immunocompromised patients with extensive lesions.

Treatment Options

Because many warts resolve on their own, treatment decisions balance lesion size, location, symptoms, cosmetic concerns, and patient preference. Below are the most evidence‑based options.

Topical Pharmacologic Therapies

• Salicylic acid (SA) preparations (10–40 %):
  – Over‑the‑counter (OTC) liquid, pad, or gel.
  – Works by keratinolysis—softening the thickened skin for gradual removal.
  – Applied daily after soaking the lesion in warm water.
  – Success rates 50–80 % after 12 weeks (Cochrane Review, 2021).
• Cantharidin (prescription):
  – Blister‑inducing agent applied by a clinician; the wart separates after 24–48 hours.
  – Useful for children because it’s painless.
• Imiquimod 5 % cream:
  – Immune response modifier that stimulates local interferon production.
  – Usually a 5‑day per week regimen for up to 16 weeks; modest efficacy (≈30 % clearance) and higher cost.
• Podophyllotoxin (OTC or prescription):
  – Antimitotic agent applied twice daily for 6 hours, repeated weekly.
  – Effective for common warts but may cause local irritation.

Procedural Treatments

• Cryotherapy (liquid nitrogen):
  – Freezes the wart tissue; usually 2–3 freeze‑thaw cycles.
  – Clearance rates 60–80 % after 1–3 sessions; may cause pain, blistering, or hypopigmentation.
• Electrosurgery & curettage:
  – Uses electric current to excise the wart, often combined with curettage (scraping).
  – High success (>90 %) but higher risk of scarring; performed under local anesthesia.
• Laser therapy (e.g., pulsed‑dye laser, CO₂ laser):
  – Targets wart vasculature; useful for resistant lesions.
  – Requires skilled operator; may be costly.
• Chemical peels (trichloroacetic acid 30–50 %):
  – Applied by a clinician; works similarly to SA but more aggressive.

Immunotherapy (for recalcitrant or extensive disease)

• Intralesional Candida antigen or mumps antigen:
  – Small injections stimulate a systemic immune response; clearance rates 70–85 % after 3–6 injections.
• Systemic agents (e.g., oral cimetidine, zinc supplementation):
  – Limited evidence; may be considered in immunocompromised patients.

Lifestyle & Home Measures

• Soak warts in warm water for 5 minutes before each SA application to enhance penetration.
• Cover lesions with waterproof bandages after topical treatment to prevent spreading.
• Avoid picking or chewing warts, which can cause autoinoculation.
• Keep feet dry and wear breathable footwear to reduce plantar wart incidence.

Living with Wart (Verruca vulgaris)

Daily management tips

• Hygiene: Wash hands regularly; use separate towels for affected areas.
• Foot care: Change socks daily, use antifungal powder if feet get sweaty, and wear flip‑flops in communal showers.
• Protective coverings: Use adhesive pads or moleskin over plantar warts to relieve pressure and reduce contagiousness.
• Monitor growth: Take photos or keep a simple log of size and symptoms; this helps gauge treatment effectiveness.
• Psychological impact: Warts on visible areas (hands, face) can cause embarrassment. Discuss concerns with a dermatologist—cosmetic removal options are available.

Special considerations

• Children: Many pediatricians adopt a “watch‑and‑wait” approach for mild warts, using SA only if lesions persist beyond 6 months.
• Pregnancy: Most topical agents are considered safe (e.g., SA), but cryotherapy should be avoided in the first trimester unless clinically necessary.
• Immunocompromised patients: May need more aggressive therapy (e.g., multiple cryotherapy sessions or intralesional immunotherapy) and closer follow‑up.

Prevention

• Hand hygiene: Wash hands after touching public surfaces and before touching your face.
• Avoid direct contact with warts: Do not pick at existing warts and keep them covered.
• Foot protection: Wear waterproof sandals in pools, gyms, and communal showers.
• Personal items: Do not share towels, razors, nail clippers, or socks.
• Skin integrity: Treat cuts, blisters, and athlete’s foot promptly; keep skin moisturized to avoid cracks.
• Strengthen immunity: Adequate sleep, balanced nutrition, regular exercise, and vaccination (especially HPV vaccine for high‑risk oncogenic strains) support overall immune health, which may help clear wart infections faster.

Complications

Although warts are benign, they can lead to problems if left untreated or mismanaged:

• Pain or functional limitation: Plantar warts can interfere with walking or running.
• Secondary bacterial infection: Scratching can introduce bacteria, leading to cellulitis or abscess.
• Scarring: Aggressive removal methods (e.g., repeated curettage) may cause permanent scar tissue.
• Spread to other body sites: Autoinoculation can result in multiple warts, especially in children.
• Psychosocial distress: Visible warts may affect self‑esteem, especially in adolescents.

When to Seek Emergency Care

---

References:

• Mayo Clinic. “Warts.” Accessed May 2024. https://www.mayoclinic.org
• Centers for Disease Control and Prevention. “Human Papillomavirus (HPV) and Warts.” 2023. https://www.cdc.gov
• National Institutes of Health, National Library of Medicine. “Verruca vulgaris.” MedlinePlus, 2024. https://medlineplus.gov
• Cochrane Database of Systematic Reviews. “Topical treatments for cutaneous warts.” 2021. https://www.cochranelibrary.com
• World Health Organization. “Human papillomavirus (HPV) and disease.” 2022. https://www.who.int
• Cleveland Clinic. “Wart Treatment Options.” 2023. https://my.clevelandclinic.org

```